@FierceMedDev: Study: Balloon implant reduced rectal damage during prostate cancer treatment. Item | Follow @FierceMedDev
@DamianFierce: Diagnostics companies gouged Medicare by almost $1B in 2011, according to the feds. Report | Follow @DamianFierce
@MarkHFierce: We need your FMD Fierce 15 nominations. Submit them courtesy of this handy link: Nomination form | Follow @MarkHFierce
> Teleflex ($TFX) bought medical device outfit Ultimate Medical for an undisclosed sum, acquiring the company's line of airway management devices and laryngeal masks. More
> Sequenom ($SQNM) has cut the ribbon on a new CLIA-certified lab in North Carolina designed to help the company handle an increase in demand for its MaterniT21 Plus prenatal diagnostic. News
> Baxter ($BAX) received an FDA warning letter over mold and hair found at plants that make infusion sets. Article
> Startup Zuga Medical raised $250,000 to help launch its FDA-cleared dental surgery implant. Item
> ConvaTec received an FDA warning letter over how it manufactures some incontinence devices. Letter
> Diagnostics company HemoSonics has raised $1.3 million to develop a test that can detect life-threatening bleeding and blood clots. Story
> Minnesota's medical device industry is a bright spot in the state's otherwise tough climate for venture funding, according to National Venture Capital Association President Mark Heesen. Report
Biotech News
@FierceBiotech: Firm tries startup's tech tricks for clinical trial recruitment. Article | Follow @FierceBiotech
@JohnCFierce: Report stirs debate over the true impact of the genomics revolution. More | Follow @JohnCFierce
@RyanMFierce: Add this AMG386 data to VTec results, and Amgen is 2 for 2 with Ph3 oncology programs this year. Devil's in the details, though. | Follow @RyanMFierce
@EmilyMFierce: At a genomics briefing on the Hill. NIH Director Francis Collins says 25,000 jobs in biomedical research will be lost due to sequestration. | Follow @EmilyMFierce
> Celgene bolsters case for closely watched arthritis drug with Ph3 data. Story
> Amgen notches positive PhIII results for top cancer drug. Report
> Amgen's big Asian push triggers $75M heart drug pact for Japan. News
Pharma News
@FiercePharma: Novartis acknowledges investigation of allegations of sales scheme in India, some employees have been fired. Story | Follow @FiercePharma
@EricPFierce: ANSM in France says no problems found in Teva packaging of Furosemide product; tampering a possibility. More | Follow @EricPFierce
@CarlyHFierce: Teva's at-risk launch of generic Protonix a bit riskier than it thought. Teva & Sun to pay $2.15B to Pfizer. Article | Follow @CarlyHFierce
> Cheaper generic combo found as effective in RA as blockbuster Enbrel. News
> Confab reviews safety of diabetes drugs like Merck's Januvia, Novo's Victoza. Article
> France finds no problems at Teva plant. More
Drug Delivery News
@MichaelGFierce: Pearl's porous particle platform nets $1.15B AstraZeneca buyout. More | Follow @MichaelGFierce
> Ocular draws funding from Baxter to support hydrogel delivery platform. Item
> Origami inspires 3-D folded structures for drug delivery. Article
> New research further reveals nano-gold's delivery potential, safety risk. Story
Biomarkers News
> Heart experts link biomarkers with high risk of "silent strokes." Report
> Stunted telomeres might flag breast cancer risk. Article
> Genetic biomarker could help scientists select cell lines for stem cell studies. More
> Cancer Research UK, Abcodia to develop blood Dx attuned to early-stage cancers. Item
> Biomarker aids in gestational diabetes risk prediction. Story